Cancer Research and Biostatistics
Cancer Research and Biostatistics reported $11.3 million in revenue and $11.7 million in expenses for calendar year 2024. Of every $100 it spent, $68.60 went to program services, $31.40 to management and general costs and $0.00 to fundraising. Its largest source of revenue was contributions and grants: 68.9% of the total. Government grants made up 68.9%. The highest compensation it reported for one person was $464,367 (PRESIDENT AND CEO). 22 people received more than $100,000 in reportable compensation. Revenue fell 11% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $12MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $11MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 68.6% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 31.4% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 68.9% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 68.9% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 30.7% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $464,367 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 3.95% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 22 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 5.5 | 13.3 |
| Independent voting board members Part VI 1a–1b | 11 of 13 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseCancer Research & Biostatistics (crab) is a national leader in designing and managing oncology clinical trials. Crab is the statistical center for swog (the largest nci cooperative group). It is crab's goal to provide support and statistical consultation for study design, protocol development, research data analysis, manuscript writing, and presentations at major conferences in oncology research. Crab values the long-standing relationships that it has with organizations to work, support and discover new and improved treatments for cancer patients and continues to make research alliances with…
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| PRESIDENT AND CEO Director/trustee, officer, 40.00 hrs/week | $425,309 | $0 | $39,058 | $464,367 |
| CFO, TREASURER Officer, 40.00 hrs/week | $215,062 | $0 | $24,301 | $239,363 |
| CTO, SECRETARY Officer, 40.00 hrs/week | $200,570 | $0 | $23,726 | $224,296 |
| SR. BIOSTATISTICIAN Highest compensated employee, 40.00 hrs/week | $180,571 | $0 | $21,842 | $202,413 |
| DIRECTOR INFORMATION SECURITY Highest compensated employee, 40.00 hrs/week | $167,758 | $0 | $21,963 | $189,721 |
| SR. BIOSTATISTICIAN Highest compensated employee, 40.00 hrs/week | $159,964 | $0 | $20,399 | $180,363 |
| DIRECTOR APPLICATIONS DEVELOPMENT Highest compensated employee, 40.00 hrs/week | $154,768 | $0 | $20,142 | $174,910 |
| PROGRAM DIRECTOR THERAPEUTIC STUDIES Highest compensated employee, 40.00 hrs/week | $149,119 | $0 | $19,640 | $168,759 |
22 people received more than $100,000 in reportable compensation from Cancer Research and Biostatistics (Part VII, line 2). Compensation of current officers, directors and key employees totaled $1.1M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b13 · 11 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bNo
- Employees Part I, line 580
- Volunteers Part I, line 611
Private foundation grants it received
1 private foundation reported grants to Cancer Research and Biostatistics totaling $241 on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from Cancer Research and Biostatistics's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Cancer Research and Biostatistics, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Cancer Research and Biostatistics spent in 2024, $68.60 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- FH Enterprise Services HoldingsMilwaukee, WI · revenue $11M · programs 55.3% · FY2025
- Immune Deficiency FoundationHanover, MD · revenue $11M · programs 70.1% · 2025
- National Foundation For Cancer ResearchRockville, MD · revenue $11M · programs 74.3% · 2024
- The Translational Genomics Research Institute FoundationPhoenix, AZ · revenue $12M · programs 83.7% · FY2025
- American Institute for Cancer ResearchArlington, VA · revenue $11M · programs 66.7% · FY2025
All medical research charities · Largest charities in Washington
Questions people ask
How much of Cancer Research and Biostatistics's spending goes to programs?
In calendar year 2024, Cancer Research and Biostatistics reported that 68.6% of its $11.7 million in expenses went to program services, 31.4% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does Cancer Research and Biostatistics pay its top executive?
The largest total compensation Cancer Research and Biostatistics reported for one person in calendar year 2024 was $464,367, for the role of PRESIDENT AND CEO (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Cancer Research and Biostatistics get its money?
Of $11.3 million in revenue in calendar year 2024, 68.9% came from contributions and grants (including 68.9% from government grants) and 30.7% from program service revenue (Form 990, Part VIII).
Is Cancer Research and Biostatistics a registered charity?
The IRS lists EIN 91-1828539 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202533169349304303 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202433029349301398 · read the filing
- 2022: Form 990 for calendar year 2022, object 202322979349300147 · read the filing
- 2021: Form 990 for calendar year 2021, object 202213199349331796 · read the filing
- 2020: Form 990 for calendar year 2020, object 202113169349313361 · read the filing
- 2019: Form 990 for calendar year 2019, object 202013219349316701 · read the filing
All filings for EIN 91-1828539: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.